BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14601519)

  • 41. Gnotobiotics and immunopathology: the use of the gnotobiotic environment to study acquired and inherited immunodeficiency diseases.
    Krakowka S; Felsburg P
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):165-75. PubMed ID: 16112740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy for immunodeficiency.
    Candotti F
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):407-15. PubMed ID: 11892066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LMO2 and gene therapy for severe combined immunodeficiency.
    Stone BD
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunodeficiency is a tough nut to CRAC: the importance of calcium flux in T cell activation.
    Carroll HP; McNaull BB; Gadina M
    Mol Interv; 2006 Oct; 6(5):253-6. PubMed ID: 17035665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen.
    Tono C; Takahashi Y; Terui K; Sasaki S; Kamio T; Tandai S; Sato T; Kudo K; Toki T; Tachibana N; Yoshioka T; Nakahata T; Morio T; Nishikomori R; Ito E
    Bone Marrow Transplant; 2007 Jun; 39(12):801-4. PubMed ID: 17417663
    [No Abstract]   [Full Text] [Related]  

  • 48. Gene therapy: therapeutic gene causing lymphoma.
    Woods NB; Bottero V; Schmidt M; von Kalle C; Verma IM
    Nature; 2006 Apr; 440(7088):1123. PubMed ID: 16641981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy for primary immunodeficiency diseases: recent progress and misgivings.
    Ariga T
    Curr Pharm Des; 2006; 12(5):549-56. PubMed ID: 16472146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 51. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon.
    Hollis RP; Nightingale SJ; Wang X; Pepper KA; Yu XJ; Barsky L; Crooks GM; Kohn DB
    Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
    Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FoxP3: a genetic link between immunodeficiency and autoimmune diseases.
    Chang X; Zheng P; Liu Y
    Autoimmun Rev; 2006 Jul; 5(6):399-402. PubMed ID: 16890893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemopoietic stem cell transplantation for genetic disorders.
    Steward CG; Jarisch A
    Arch Dis Child; 2005 Dec; 90(12):1259-63. PubMed ID: 16301554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunology in the medical practice. XXXI. Hereditary immune deficiencies: relationship between clinical symptoms and abnormalities of the immune system].
    Vossen JM; Kuijpers TW
    Ned Tijdschr Geneeskd; 2000 Jul; 144(31):1474-80. PubMed ID: 10941433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary disorders of erythrocyte enzymes in non-glycolytic metabolic pathways.
    Paglia DE; Valentine WN
    Haematologia (Budap); 1982 Dec; 15(4):381-8. PubMed ID: 7186478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The molecular basis of primary immunodeficiency syndrome and the current therapeutic approach for the disease].
    Morio T
    Rinsho Byori; 1999 Jun; 47(6):519-24. PubMed ID: 10434568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunodeficiency syndromes associated with inherited metabolic disorders.
    Cowan MJ; Ammann AJ
    Clin Haematol; 1981 Feb; 10(1):139-59. PubMed ID: 6260406
    [No Abstract]   [Full Text] [Related]  

  • 59. Immune deficiencies: introduction.
    Etzioni A
    Isr Med Assoc J; 2002 Jan; 4(1):50. PubMed ID: 11802312
    [No Abstract]   [Full Text] [Related]  

  • 60. Syndromes associated with immunodeficiency.
    Ming JE; Stiehm ER; Graham JM
    Adv Pediatr; 1999; 46():271-351. PubMed ID: 10645468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.